Real-World Efficacy and Hematologic Toxicity of Azacitidine and Venetoclax in a Cohort of Elderly Patients Unfit for Intensive Chemotherapy With Newly Diagnosed Acute Myeloid Leukemia

被引：0
|
作者：
Wysoglad, Hubert [1 ,2 ]
Krawczyk, Katarzyna [2 ,3 ]
Ochrem, Bogdan [2 ,3 ]
Madry, Krzysztof [1 ]
Drozd-Sokolowska, Joanna [1 ]
Sacha, Tomasz [2 ,3 ]
Basak, Grzegorz [1 ]
机构：
[1] Med Univ Warsaw, Dept Hematol Transplantol & Internal Med, Warsaw, Poland
[2] Univ Hosp Krakow, Dept Hematol, Krakow, Poland
[3] Jagiellonian Univ Med Coll, Dept Hematol, Krakow, Poland
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
acute myeloid leukemia; azacitidine; venetoclax; real-world evidence;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
AML-384
引用
收藏
页码：S294 / S294
页数：1
相关论文
共 50 条
  • [41] Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia - A Retrospective Study of a Real-World Setting
    Saiz-Rodriguez, Miriam
    Cuevas, Beatriz
    Alvarez, Rodolfo
    Cuello, Rebeca
    Belen Vidriales, Maria
    Olivier, Carmen
    Recio, Isabel
    Campuzano, Veronica
    Yeguas, Ana
    Cuevas, Victoria
    Javier Diaz-Galvez, Francisco
    Ruano, Teresa
    Avendano, Alejandro
    Duenas, Veronica
    Garcia, Covadonga
    Jose Gonzalez-Lopez, Tomas
    Olazabal, Juan
    Serra, Fe
    De Vicente, Pilar
    Hermida, Gerardo
    Labrador, Jorge
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2020, 20 : S173 - S174
  • [42] Venetoclax and Azacitidine Treatment in Relapsed Acute Myeloid Leukemia after Hematopoietic Stem Cell Transplantation: A Cohort Study in the Real-World Setting of a Tertiary Center
    Goker, Hakan
    Cinar, Olgu Erkin
    Demiroglu, Haluk
    Malkan, Uemit Yavuz
    Karakulak, Elifcan Aladag
    Buyukasik, Yahya
    TURKISH JOURNAL OF HEMATOLOGY, 2023, 40 (03) : 213 - 215
  • [43] Venetoclax-Based Regimen for Elderly Patients with Acute Myeloid Leukemia: A Real-World Experience from a Tertiary Center in Taiwan
    Chen, Lo -Ho
    Chang, Yu-Cheng
    Lim, Ken -Hong
    INTERNATIONAL JOURNAL OF GERONTOLOGY, 2023, 17 (04) : 243 - 246
  • [44] Outcomes Are Similar After Allogeneic Hematopoietic Stem Cell Transplant for Newly Diagnosed Acute Myeloid Leukemia Patients who Received Venetoclax plus Azacitidine Versus Intensive Chemotherapy
    Winters, Amanda C.
    Bosma, Grace
    Abbott, Diana
    Minhajuddin, Mohd
    Jordan, Craig
    Pollyea, Daniel A.
    Gutman, Jonathan A.
    TRANSPLANTATION AND CELLULAR THERAPY, 2022, 28 (10): : 694.e1 - 694.e9
  • [45] Impact of KIT mutation on efficacy of venetoclax and hypomethylating agents in newly diagnosed acute myeloid leukemia
    Wenxiu Shu
    Qianqian Yang
    Donghua He
    Yi Li
    Jing Le
    Qianqian Cai
    Hui Dai
    Liufei Luo
    Bingrong Chen
    Yuan Gong
    Dian Jin
    European Journal of Medical Research, 30 (1)
  • [46] The Efficacy and Safety of Homoharringtonine Added to Venetoclax and Azacitidine in the Frontline Treatment of Newly Diagnosed Acute Myeloid Leukemia, a Multi-Center Exploratory Cohort Study
    Yu, Guopan
    Yao, Zurong
    Yin, Zhao
    Zhang, Yu
    Zhao, Weihua
    Weng, Guangyang
    Guo, Ziwen
    Sun, Zhiqiang
    Shi, Pengcheng
    Jiang, Xuejie
    Xu, Dan
    Xuan, Li
    Liu, Qifa
    BLOOD, 2024, 144 : 4283 - 4283
  • [47] Pracinostat combined with azacitidine in newly diagnosed adult acute myeloid leukemia (AML) patients unfit for standard induction chemotherapy: PRIMULA phase III study
    Garcia-Manero, Guillermo
    Kazmierczak, Maciej
    Wierzbowska, Agnieszka
    Fong, Chun Yew
    Keng, Michael K.
    Ballinari, Gianluca
    Scarci, Francesco
    Ades, Lionel
    LEUKEMIA RESEARCH, 2024, 140
  • [48] Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
    Maurillo, Luca
    Buccisano, Francesco
    Spagnoli, Alessandra
    Voso, Maria Teresa
    Fianchi, Luana
    Papayannidis, Cristina
    Gaidano, Gian Luca
    Breccia, Massimo
    Musto, Pellegrino
    De Bellis, Eleonora
    Del Principe, Maria Ilaria
    Lunghi, Monia
    Lessi, Federica
    Martinelli, Giovanni
    Venditti, Adriano
    ANNALS OF HEMATOLOGY, 2018, 97 (10) : 1767 - 1774
  • [49] Comparative analysis of azacitidine and intensive chemotherapy as front-line treatment of elderly patients with acute myeloid leukemia
    Luca Maurillo
    Francesco Buccisano
    Alessandra Spagnoli
    Maria Teresa Voso
    Luana Fianchi
    Cristina Papayannidis
    Gian Luca Gaidano
    Massimo Breccia
    Pellegrino Musto
    Eleonora De Bellis
    Maria Ilaria Del Principe
    Monia Lunghi
    Federica Lessi
    Giovanni Martinelli
    Adriano Venditti
    Annals of Hematology, 2018, 97 : 1767 - 1774
  • [50] Comparison between azacitidine and decitabine as front-line therapy in elderly acute myeloid leukemia patients not eligible for intensive chemotherapy
    Maurillo, L.
    Spagnoli, A.
    Candoni, A.
    Papayannidis, C.
    Borlenghi, E.
    Lazzarotto, D.
    Fianchi, L.
    Sciume, M.
    Zannier, M. E.
    Buccisano, F.
    Del Principe, M. I.
    Mancini, V.
    Breccia, M.
    Fanin, R.
    Todisco, E.
    Lunghi, M.
    Palmieri, R.
    Fracchiolla, N.
    Musto, P.
    Rossi, G.
    Venditti, A.
    LEUKEMIA RESEARCH, 2023, 127
12345